ANIP ANI Pharmaceuticals, Inc.
$70.19▼ -1.78%
Healthcare
Other
After hours
$70.19▲ +0.00%
Sep 11, 7:30 PM ET
Volume 329.2K
Avg Volume (10D) 322.4K
Key Metrics & Fundamentals
Market Cap
$1.61B
P/E Ratio
15.3
Div Yield
–%
52W Range
69.58 - 99.39
% vs 50 MA
-9.50%
% vs 200 MA
-11.30%
RSI-14
35.6
MACD Histogram
-0.1600
Beta (1Y vs SPY)
0.22
Free Cash Flow
$53.62M
Gross Rev
$266.04M
Gross Profit
$165.89M
EBITDA
$59.01M
COGS
$100.16M
Operating Exp
$126.05M
Operating Income
$39.84M
EBIT
$39.84M
Pretax Income
$37.10M
Net Income
$24.71M
EPS (Diluted)
1.05
Price & Volume History
Loading chart…
Recent News
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board
Simply Wall St. · Sep 4, 2026 10:14 PM
ANI Pharmaceuticals to Present at September Investor Conferences
GlobeNewswire · Sep 3, 2026 10:55 AM
2 Value Stocks on Our Watchlist and 1 We Find Risky
StockStory · Sep 1, 2026 10:50 AM
2 Reasons to Like ANIP (and 1 Not So Much)
StockStory · Aug 27, 2026 11:45 PM
1 Russell 2000 Stock to Target This Week and 2 We Brush Off
StockStory · Aug 24, 2026 3:13 PM
ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors
GlobeNewswire · Aug 24, 2026 10:55 AM
The Top 5 Analyst Questions From ANI Pharmaceuticals’s Q2 Earnings Call
StockStory · Aug 16, 2026 9:09 AM
Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks
StockStory · Aug 15, 2026 5:49 PM
Should You Buy ANIP as Low Valuation Meets Cortrophin Execution Risk?
Zacks · Aug 14, 2026 5:15 PM
ANIP's Cortrophin Guidance Cut Raises the Bar for Second-Half Growth
Zacks · Aug 14, 2026 5:12 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ANIP's money flow as a full page
Social Sentiment
Avg -0.30 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.